Australia’s largest skin cancer study

NewsGuard 100/100 Score

More than 400,000 people will be diagnosed with some form of skin cancer this year and the most deadly form of the disease, melanoma, will claim more than a thousand lives in Australia say researchers. Queensland has the highest rate of skin cancer in the world with fair-skinned people being most affected with the strong subtropical sun.

Now a team of scientists at the Queensland Institute of Medical Research are about to commence on the largest skin cancer research study ever conducted in Australia. The study will allow doctors to predict a person’s future risk of developing skin cancer. The Institute hopes data will be collected from more than 200,000 people over a decade or longer.

Associate Professor David Whiteman from the Queensland Institute of Medical Research explains that it is not just fair skin and the sun that is responsible for the cancer. He said, “There are some genetic backgrounds that pre-dispose people to have a higher risk of skin cancer, even if their skin colours are olive or darker and we also know that for different types of skin cancer, particularly for melanoma there do appear to be important periods of time during a person's development, you know, during their adolescence and childhood when it appears that the effects of sunlight are particularly nasty and dangerous for the cells of the skin. So it’s this kind of information now that we’re trying to drill down on.”

The study will be based on surveys that ask about previous sun exposure, freckles and moles, skin type, family history and other factors. This information would be linked to Medicare records and significant factors would be unearthed and a better understanding of skin cancer is expected. Dr. Whiteman said, “While there’s a general tendency for large levels of sun exposure to contribute to melanoma and skin cancer, it's not always the case and again this is where the interplay of genetics and environment play a role… So by doing very large studies and looking at different groupings of risk factors, we can start to sort out the different pathways through which these cancers arise.”

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2020, April 03). Australia’s largest skin cancer study. News-Medical. Retrieved on April 27, 2024 from https://www.news-medical.net/news/20101129/Australias-largest-skin-cancer-study.aspx.

  • MLA

    Mandal, Ananya. "Australia’s largest skin cancer study". News-Medical. 27 April 2024. <https://www.news-medical.net/news/20101129/Australias-largest-skin-cancer-study.aspx>.

  • Chicago

    Mandal, Ananya. "Australia’s largest skin cancer study". News-Medical. https://www.news-medical.net/news/20101129/Australias-largest-skin-cancer-study.aspx. (accessed April 27, 2024).

  • Harvard

    Mandal, Ananya. 2020. Australia’s largest skin cancer study. News-Medical, viewed 27 April 2024, https://www.news-medical.net/news/20101129/Australias-largest-skin-cancer-study.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
First UK real-world study shows promise for sacituzumab govitecan in metastatic breast cancer